Literature DB >> 19293384

Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.

Megha Makam1, Daisy Diaz, Julie Laval, Yael Gernez, Carol K Conrad, Colleen E Dunn, Zoe A Davies, Richard B Moss, Leonore A Herzenberg, Leonard A Herzenberg, Rabindra Tirouvanziam.   

Abstract

Cystic fibrosis (CF) patients undergo progressive airway destruction caused in part by chronic neutrophilic inflammation. While opportunistic pathogens infecting CF airways can cause inflammation, we hypothesized that host-derived metabolic and stress signals would also play a role in this process. We show that neutrophils that have entered CF airways have increased phosphorylation of the eukaryotic initiation factor 4E and its partner the 4E-binding protein 1; 2 key effectors in the growth factor- and amino acid-regulated mammalian target of rapamycin (mTOR) pathway. Furthermore CF airway neutrophils display increased phosphorylation of the cAMP response element binding protein (CREB), a major transcriptional coactivator in stress signaling cascades. These active intracellular pathways are associated with increased surface expression of critical adaptor molecules, including the growth factor receptor CD114 and the receptor for advanced glycation end-products (RAGE), a CREB inducer and sensor for host-derived damage-associated molecular patterns (DAMPs). Most CF airway fluids lack any detectable soluble RAGE, an inhibitory decoy receptor for DAMPs. Concomitantly, CF airway fluids displayed high and consequently unopposed levels of S100A12; a potent mucosa- and neutrophil-derived DAMP. CF airway neutrophils also show increased surface levels of 2 critical CREB targets, the purine-recycling enzyme CD39 and the multifunctional, mTOR-inducing CXCR4 receptor. This coordinated set of events occurs in all patients, even in the context of minimal airway inflammation and well-preserved lung function. Taken together, our data demonstrate an early and sustained activation of host-responsive metabolic and stress pathways upon neutrophil entry into CF airways, suggesting potential targets for therapeutic modulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19293384      PMCID: PMC2667067          DOI: 10.1073/pnas.0813410106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Extensive surface phenotyping of alveolar macrophages in interstitial lung disease.

Authors:  M L Taylor; P W Noble; B White; R Wise; M C Liu; B S Bochner
Journal:  Clin Immunol       Date:  2000-01       Impact factor: 3.969

Review 2.  Transcriptional regulation by the phosphorylation-dependent factor CREB.

Authors:  B Mayr; M Montminy
Journal:  Nat Rev Mol Cell Biol       Date:  2001-08       Impact factor: 94.444

3.  Oxidative stress in cystic fibrosis: dietary and metabolic factors.

Authors:  L G Wood; D A Fitzgerald; P G Gibson; D M Cooper; C E Collins; M L Garg
Journal:  J Am Coll Nutr       Date:  2001-04       Impact factor: 3.169

4.  Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease.

Authors:  S R Thomas; A Ray; M E Hodson; T L Pitt
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

5.  Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element.

Authors:  Anthony D Cristillo; Helene C Highbarger; Robin L Dewar; Dimiter S Dimitrov; Hana Golding; Barbara E Bierer
Journal:  FASEB J       Date:  2002-03       Impact factor: 5.191

6.  Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.

Authors:  Henri J Huttunen; Juha Kuja-Panula; Heikki Rauvala
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

7.  Expression of S100A12 (EN-RAGE) in cystic fibrosis.

Authors:  D Foell; S Seeliger; T Vogl; H-G Koch; H Maschek; E Harms; C Sorg; J Roth
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

8.  Primary inflammation in human cystic fibrosis small airways.

Authors:  Rabindra Tirouvanziam; Ibrahim Khazaal; Bruno Péault
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

9.  Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.

Authors:  Melissa G Hunter; Lawrence J Druhan; Pam R Massullo; Belinda R Avalos
Journal:  Am J Hematol       Date:  2003-11       Impact factor: 10.047

10.  Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migration.

Authors:  Ravi M Rao; Travis V Betz; Deanna J Lamont; Michael B Kim; Sunil K Shaw; Richard M Froio; Françoise Baleux; Fernando Arenzana-Seisdedos; Ronen Alon; Francis W Luscinskas
Journal:  J Exp Med       Date:  2004-09-20       Impact factor: 14.307

View more
  48 in total

1.  In vivo evaluation of adeno-associated virus gene transfer in airways of mice with acute or chronic respiratory infection.

Authors:  Melissa Myint; Maria P Limberis; Peter Bell; Suryanarayan Somanathan; Angela Haczku; James M Wilson; Scott L Diamond
Journal:  Hum Gene Ther       Date:  2014-09-22       Impact factor: 5.695

Review 2.  Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Authors:  Dominik Hartl; Rabindra Tirouvanziam; Julie Laval; Catherine M Greene; David Habiel; Lokesh Sharma; Ali Önder Yildirim; Charles S Dela Cruz; Cory M Hogaboam
Journal:  J Innate Immun       Date:  2018-02-13       Impact factor: 7.349

3.  Mature cystic fibrosis airway neutrophils suppress T cell function: evidence for a role of arginase 1 but not programmed death-ligand 1.

Authors:  Sarah A Ingersoll; Julie Laval; Osric A Forrest; Marcela Preininger; Milton R Brown; Dalia Arafat; Greg Gibson; Vin Tangpricha; Rabindra Tirouvanziam
Journal:  J Immunol       Date:  2015-04-29       Impact factor: 5.422

4.  Methods for Extraction and Detection of Pf Bacteriophage DNA from the Sputum of Patients with Cystic Fibrosis.

Authors:  Elizabeth B Burgener; Patrick R Secor; Michael C Tracy; Johanna M Sweere; Elisabeth M Bik; Carlos E Milla; Paul L Bollyky
Journal:  Phage (New Rochelle)       Date:  2020-06-16

Review 5.  RAGE: a new frontier in chronic airways disease.

Authors:  Maria B Sukkar; Md Ashik Ullah; Wan Jun Gan; Peter A B Wark; Kian Fan Chung; J Margaret Hughes; Carol L Armour; Simon Phipps
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

6.  Benzyloxycarbonyl-proline-prolinal (ZPP): Dual complementary roles for neutrophil inhibition.

Authors:  D W Russell; M Hardison; K R Genschmer; T Szul; P E Bratcher; M Abdul Roda; X Xu; L Viera; J E Blalock; A Gaggar; B D Noerager
Journal:  Biochem Biophys Res Commun       Date:  2019-08-07       Impact factor: 3.575

7.  Rapid diversification of Pseudomonas aeruginosa in cystic fibrosis lung-like conditions.

Authors:  Alana Schick; Rees Kassen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

8.  Elastase Exocytosis by Airway Neutrophils Is Associated with Early Lung Damage in Children with Cystic Fibrosis.

Authors:  Camilla Margaroli; Luke W Garratt; Hamed Horati; A Susanne Dittrich; Timothy Rosenow; Samuel T Montgomery; Dario L Frey; Milton R Brown; Carsten Schultz; Lokesh Guglani; Anthony Kicic; Limin Peng; Bob J Scholte; Marcus A Mall; Hettie M Janssens; Stephen M Stick; Rabindra Tirouvanziam
Journal:  Am J Respir Crit Care Med       Date:  2019-04-01       Impact factor: 21.405

Review 9.  The receptor for advanced glycation end products (RAGE) and the lung.

Authors:  Stephen T Buckley; Carsten Ehrhardt
Journal:  J Biomed Biotechnol       Date:  2010-01-19

Review 10.  Neutrophils come of age in chronic inflammation.

Authors:  Simone Caielli; Jacques Banchereau; Virginia Pascual
Journal:  Curr Opin Immunol       Date:  2012-11-03       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.